Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors — Stella

Home/Advanced Solid Tumor/

View on ClinicalTrials.gov

Recruiting

Back to Advanced Solid Tumor trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Union Hospital Tong Ji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei

Key details

Phase

Early testing / Safety & dosing

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Enrollment target

~176 participants

Started

June 2022

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.